2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Uses, Dosage, Side Effects and more
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).
| Trade Name | 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
| Generic | Hydroxypropyl betadex |
| Hydroxypropyl betadex Other Names | 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
| Type | |
| Formula | C60H106O40 |
| Weight | Average: 1467.468 Monoisotopic: 1466.626038213 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
